As of 2025-10-23, the Intrinsic Value of Akero Therapeutics Inc (AKRO) is -17.75 USD. This AKRO valuation is based on the model Peter Lynch Fair Value. With the current market price of 53.61 USD, the upside of Akero Therapeutics Inc is -133.11%.
Based on its market price of 53.61 USD and our intrinsic valuation, Akero Therapeutics Inc (AKRO) is overvalued by 133.11%.
Note: result may not be accurate due to the invalid valuation result of Peter Lynch's fair value model.
| Range | Selected | Upside | |
| a | |||
| Fair Value | -17.75 - -17.75 | -17.75 | -133.11% |
| DDM - Stable | (32.83) - (117.16) | (74.99) | -239.9% |
| DDM - Multi | (0.47) - (1.26) | (0.68) | -101.3% |
| Market Cap (mil) | 4,297.38 |
| Beta | 0.42 |
| Outstanding shares (mil) | 80.16 |
| Enterprise Value (mil) | 4,297.38 |
| Market risk premium | 4.60% |
| Cost of Equity | 9.14% |
| Cost of Debt | 5.00% |
| WACC | 9.09% |